UC7AI095321↗

Trustees of Boston University received this grant or assistance award from National Institutes of Health: $46.00M obligated so far for allergy and infectious diseases research. Its latest action was on 2026-08-20.

Key facts · data as of Oct 25, 2026

Recipient
Trustees of Boston University
Awarding agency
National Institutes of Health (Department of Health and Human Services)
Obligated to date
$46.00M

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.

Cite this page: SpendQuery, Award UC7AI095321, data as of Oct 25, 2026, https://spendquery.com/award?id=ASST_NON_UC7AI095321_075

NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS

Cooperative Agreement (B) · National Institutes of Health · to Trustees of Boston University (UEI FBYMGMHW4X95) · data as of 2026-10-25

Obligated to date$46.00M12 actions
Period2023-02-06 → 2026-08-20first to last action

What it is

Program
Allergy and Infectious Diseases Research (Assistance Listing 93.855)
Where the work is
Suffolk, MA · district MA-07

The research project

NEIDL-Environmental Health and Biosafety Regulations an Requirements · National Institute of Allergy and Infectious Diseases (NIAID) · led by Kevin Michael Tuohey, BOSTON UNIVERSITY MEDICAL CAMPUS

“Environmental Health and Biosafety Regulations and Requirements Abstract The Environmental Health and Biosafety Regulations and Requirements (EHBRR) Core provides the foundation for the safe, compliant, and transparent operation of the National Emerging Infectious Diseases Laboratories (NEIDL).” Full abstract on RePORTER ↗

NIH funding by fiscal year: FY2019 $553.0K · FY2020 $22.89M · FY2021 $23.00M · FY2022 $23.00M · FY2023 $23.00M · FY2024 $23.00M · FY2025 $23.00M · FY2026 $23.00M ($161.44M in all) · project period 2014-06-01 to 2031-07-31.

Source: NIH RePORTER, project UC7AI095321. RePORTER counts NIH's awards by year; USAspending's obligations above count each action.

Obligations by fiscal year

FY2023$11.50M
FY2024$11.50M
FY2025$11.50M
FY2026$11.50M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subrecipients: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

12 actions since 2023-02-06. Each is a modification or amendment with the money it added or took back.

DateAmendmentKindAmountWhat the agency wrote
2026-08-20002Continuation$11.50MBOSTON UNIVERSITY NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES - OVERALL ABSTRACT THE BOSTON UNIVERSITY (BU) NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL) IS A NATIONAL BIOCONTAINMENT RESOURCE HOUSING BSL-4 LABORATORIES WITHIN ONE OF THE…
2026-08-19001Revision$0BOSTON UNIVERSITY NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES - OVERALL ABSTRACT THE BOSTON UNIVERSITY (BU) NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL) IS A NATIONAL BIOCONTAINMENT RESOURCE HOUSING BSL-4 LABORATORIES WITHIN ONE OF THE…
2026-04-21000Revision$0BOSTON UNIVERSITY NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES - OVERALL ABSTRACT THE BOSTON UNIVERSITY (BU) NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL) IS A NATIONAL BIOCONTAINMENT RESOURCE HOUSING BSL-4 LABORATORIES WITHIN ONE OF THE…
2025-08-21001Revision$0NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS - OVERALL ABSTRACT THE NATIONAL BIOCONTAINMENT LABORATORY (NBL) AT BOSTON UNIVERSITY (BU) IS KNOWN AS THE NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL). IT IS OWNED AND OPERATED BY BU…
2025-07-09000Continuation$11.50MNATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS - OVERALL ABSTRACT THE NATIONAL BIOCONTAINMENT LABORATORY (NBL) AT BOSTON UNIVERSITY (BU) IS KNOWN AS THE NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL). IT IS OWNED AND OPERATED BY BU…
2024-08-26003Revision$0NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS - OVERALL ABSTRACT THE NATIONAL BIOCONTAINMENT LABORATORY (NBL) AT BOSTON UNIVERSITY (BU) IS KNOWN AS THE NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL). IT IS OWNED AND OPERATED BY BU…
2024-07-31002Continuation$11.50MNATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS - OVERALL ABSTRACT THE NATIONAL BIOCONTAINMENT LABORATORY (NBL) AT BOSTON UNIVERSITY (BU) IS KNOWN AS THE NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL). IT IS OWNED AND OPERATED BY BU…
2024-05-23001Revision$0NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS - OVERALL ABSTRACT THE NATIONAL BIOCONTAINMENT LABORATORY (NBL) AT BOSTON UNIVERSITY (BU) IS KNOWN AS THE NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL). IT IS OWNED AND OPERATED BY BU…
2023-12-04000Revision$0NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS - OVERALL ABSTRACT THE NATIONAL BIOCONTAINMENT LABORATORY (NBL) AT BOSTON UNIVERSITY (BU) IS KNOWN AS THE NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL). IT IS OWNED AND OPERATED BY BU…
2023-08-08002Revision$0NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS - OVERALL ABSTRACT THE NATIONAL BIOCONTAINMENT LABORATORY (NBL) AT BOSTON UNIVERSITY (BU) IS KNOWN AS THE NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL). IT IS OWNED AND OPERATED BY BU…
2023-07-24001Continuation$11.50MNATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS - OVERALL ABSTRACT THE NATIONAL BIOCONTAINMENT LABORATORY (NBL) AT BOSTON UNIVERSITY (BU) IS KNOWN AS THE NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL). IT IS OWNED AND OPERATED BY BU…
2023-02-06000Revision$0NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS - OVERALL ABSTRACT THE NATIONAL BIOCONTAINMENT LABORATORY (NBL) AT BOSTON UNIVERSITY (BU) IS KNOWN AS THE NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES (NEIDL). IT IS OWNED AND OPERATED BY BU…

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗